Lobeglitazone, a PPAR/ agonist licensed in Korea for treatment of T2DM, has recently been studied in a pilot trial recruiting diabetic NASH patients diagnosed by CAP values on Fibroscan
A 2021 analysis in Menopause (the journal of the Menopause Society) found that GLP-1 receptor agonists reduced visceral adipose tissue in postmenopausal women independent of total weight loss, suggesting a mechanism beyond simple caloric restriction
You may also need to check your insurance
A: Theres no doubt about it - most vitamin C serums have a unique smell
If you experience any suspected side effects from your medication or supplements, report them through the MHRA Yellow Card Scheme, which helps monitor the safety of medicines and supplements in the UK
The FDA's adverse event reporting system has documented 489 reports of patients experiencing anxiety, depression, or suicidal thoughts while taking semaglutide medications, including 96 cases of suicidal thoughts [1]
